APP and early-onset autosomal dominant Alzheimer disease: Deletion of bec-1 inverts longevity in worms and a recent study demonstrated Becn1 as potential therapeutic target in Alzheimer's disease, where lack of Becn1 modulates amyloid precursor protein metabolism and promotes neurodegeneration in mice [8].